✦ LIBER ✦

0153 Routine clinical usage of trastuzumab (Herceptin®) in the adjuvant treatment of breast cancer in Germany - a prospective registry study

✍ Scribed by P. Dall; M. Klausmann; F. Khandan; H. Urbanczyk; W. Schoenegg; J. Eggert; A. Prechtl; A. Hinke; C. Lerchenmüller

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impact of trastuzumab treatment beyond d

✍ Jackisch, C.; Welslau, M.; Schoenegg, W.; Selbach, J.; Harich, H.-D.; Schröder, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 541 KB

357 Tolerance of concurrent adjuvant tra

✍ L. Caussa; N. Gault; Y.M. Kirova; J.Y. Pierga; A. Savignoni; F. Campana; R. Dend 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 46 KB

A 3-Year Prospective Study of the Effect

✍ Ahles, T.A. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 64 KB

A pilot study of adjuvant nanoparticle a

✍ Denise Yardley; Howard Burris; Nancy Peacock; Eric Raefsky; Marianne Melnik; Rog 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 171 KB

P280 Identification of factors associate

✍ R. Sala; P. Dodyk; M. Varela; G. Lerzo; C. Blajman; J. Zarba; J. Lacava; A. Alva 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 38 KB

Radiotherapy concurrent with trastuzumab

✍ E.A. Perez; Halyard; T. Pisansky; V.J. Suman; A. Dueck; N. Davidson; S. Martino; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 142 KB